University of Nebraska: Peripheral Arterial Disease trials

The registry lists 13 Peripheral Arterial Disease studies with University of Nebraska as lead sponsor. 5 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 4 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Detecting Peripheral Artery Disease With the PulseRecruitingNCT07226193Not applicable
• SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial DiseaseRecruitingNCT06480786Not applicable
• MitoQ Treatment of Claudication: Myofiber and Micro-vessel PathologyRecruitingNCT06409949Not applicable
• Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery DiseaseRecruitingNCT06319339Early Phase 1
• Ramipril Treatment of Claudication: Oxidative Damage and Muscle FibrosisRecruitingNCT02842424Phase 4
• Exoskeleton Variability OptimizationTerminatedNCT04338815Not applicableResults posted
• Dietary Nitrate Supplementation and ThermoregulationCompletedNCT03506646Not applicableResults posted
• Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease PatientsCompletedNCT03506633Not applicableResults posted
• Improving Mobility in Peripheral Artery Disease Using an Ankle Foot OrthosisCompletedNCT02902211Not applicableResults posted
• Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery DiseaseWithdrawnNCT06389149Not applicable
• Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery DiseaseWithdrawnNCT03493412Phase 4
• Mechanisms That Produce the Leg Dysfunction of Claudication & Treatment StrategiesCompletedNCT01970332Not applicable
• Lower Extremity Regional Anesthesia and Infrainguinal Bypass GraftingWithdrawnNCT01803165